AbbVie Inc. (TSX:ABBV)
30.59
-1.18 (-3.71%)
At close: Feb 4, 2026
AbbVie Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 61,160 | 56,334 | 54,318 | 58,054 | 56,197 | |
Revenue Growth (YoY) | 8.57% | 3.71% | -6.44% | 3.30% | 22.69% |
Cost of Revenue | 18,204 | 16,689 | 16,726 | 16,527 | 17,314 |
Gross Profit | 42,956 | 39,645 | 37,592 | 41,527 | 38,883 |
Selling, General & Admin | 14,010 | 13,189 | 12,904 | 14,584 | 11,872 |
Research & Development | 9,096 | 8,131 | 7,038 | 6,487 | 6,820 |
Other Operating Expenses | -241 | -7 | -10 | 228 | 432 |
Operating Expenses | 22,865 | 21,313 | 19,932 | 21,299 | 19,124 |
Operating Income | 20,091 | 18,332 | 17,660 | 20,228 | 19,759 |
Interest Expense | -2,627 | -2,808 | -2,224 | -2,230 | -2,423 |
Interest & Investment Income | - | 648 | 540 | 186 | 39 |
Currency Exchange Gain (Loss) | -58 | -21 | -146 | -148 | -51 |
Other Non Operating Income (Expenses) | -5,793 | 271 | 190 | 142 | 55 |
EBT Excluding Unusual Items | 11,613 | 16,422 | 16,020 | 18,178 | 17,379 |
Merger & Restructuring Charges | - | -792 | -119 | -539 | -587 |
Gain (Loss) on Sale of Assets | - | - | - | 172 | - |
Asset Writedown | - | -4,476 | -4,230 | -876 | - |
Legal Settlements | - | -910 | 485 | - | - |
Other Unusual Items | - | -3,771 | -5,128 | -2,761 | -2,679 |
Pretax Income | 6,597 | 3,716 | 6,250 | 13,477 | 12,989 |
Income Tax Expense | 2,364 | -570 | 1,377 | 1,632 | 1,440 |
Earnings From Continuing Operations | 4,233 | 4,286 | 4,873 | 11,845 | 11,549 |
Minority Interest in Earnings | -7 | -8 | -10 | -9 | -7 |
Net Income | 4,226 | 4,278 | 4,863 | 11,836 | 11,542 |
Preferred Dividends & Other Adjustments | - | 40 | 43 | 54 | 74 |
Net Income to Common | 4,226 | 4,238 | 4,820 | 11,782 | 11,468 |
Net Income Growth | -1.22% | -12.03% | -58.91% | 2.55% | 150.04% |
Shares Outstanding (Basic) | 1,773 | 1,769 | 1,768 | 1,771 | 1,770 |
Shares Outstanding (Diluted) | 1,791 | 1,773 | 1,773 | 1,778 | 1,777 |
Shares Change (YoY) | 1.00% | - | -0.28% | 0.06% | 6.22% |
EPS (Basic) | 2.38 | 2.40 | 2.73 | 6.65 | 6.48 |
EPS (Diluted) | 2.36 | 2.39 | 2.72 | 6.63 | 6.45 |
EPS Growth | -1.26% | -12.13% | -58.97% | 2.79% | 137.13% |
Free Cash Flow | - | 17,832 | 22,062 | 24,248 | 21,990 |
Free Cash Flow Per Share | - | 10.06 | 12.44 | 13.64 | 12.38 |
Dividend Per Share | - | 6.290 | 5.990 | 5.710 | 5.310 |
Dividend Growth | - | 5.01% | 4.90% | 7.53% | 9.71% |
Gross Margin | 70.23% | 70.38% | 69.21% | 71.53% | 69.19% |
Operating Margin | 32.85% | 32.54% | 32.51% | 34.84% | 35.16% |
Profit Margin | 6.91% | 7.52% | 8.87% | 20.29% | 20.41% |
Free Cash Flow Margin | - | 31.65% | 40.62% | 41.77% | 39.13% |
EBITDA | 28,294 | 26,718 | 26,358 | 28,695 | 28,280 |
EBITDA Margin | 46.26% | 47.43% | 48.52% | 49.43% | 50.32% |
D&A For EBITDA | 8,203 | 8,386 | 8,698 | 8,467 | 8,521 |
EBIT | 20,091 | 18,332 | 17,660 | 20,228 | 19,759 |
EBIT Margin | 32.85% | 32.54% | 32.51% | 34.84% | 35.16% |
Effective Tax Rate | 35.83% | - | 22.03% | 12.11% | 11.09% |
Advertising Expenses | - | 2,100 | 2,200 | 2,000 | 2,100 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.